Structural basis for the reaction cycle of DASS dicarboxylate transporters
Abstract
Citrate, α-ketoglutarate and succinate are TCA cycle intermediates that also play essential roles in metabolic signaling and cellular regulation. These di- and tricarboxylates are imported into the cell by the divalent anion sodium symporter (DASS) family of plasma membrane transporters, which contains both cotransporters and exchangers. While DASS proteins transport substrates via an elevator mechanism, to date structures are only available for a single DASS cotransporter protein in a substrate-bound, inward-facing state. We report multiple cryo-EM and X-ray structures in four different states, including three hitherto unseen states, along with molecular dynamics simulations, of both a cotransporter and an exchanger. Comparison of these outward- and inward-facing structures reveal how the transport domain translates and rotates within the framework of the scaffold domain through the transport cycle. Additionally, we propose that DASS transporters ensure substrate coupling by a charge-compensation mechanism, and by structural changes upon substrate release.
Data availability
Cryo-EM maps and models have been deposited in the Protein Data Bank and EMDB database, respectively, for VcINDY-Na+ in amphipol (6WU3, EMD-21904), VcINDY-Na+-Fab84 in nanodisc (6WW5, EMD-21928), LaINDY-apo (6WU1, EMD-21902), LaINDY-aKG (6WU4, EMD-21905), and LaINDY-malate (6WU2, EMD-21903). X-ray derived models and diffraction data have been deposited in the Protein Data Bank for LaINDY-malate-aKG (6WTW) and VcINDY-TTP (6WTX). Coordinates of representative LaINDY structures from MD simulations of the Co-S and Ci-S states will be made publicly available on Zenodo (DOI: 10.5281/zenodo.3965996). Bond length analysis code is available at https://github.com/DavidBSauer/bond_length_analysis.
Article and author information
Author details
Funding
National Institutes of Health (R01NS108151)
- Da-Neng Wang
Department of Defense (W81XWH-16-1-0153)
- David B Sauer
National Science Foundation (1746047)
- Noah Trebesch
National Institutes of Health (T32GM088118)
- Nicolette Cocco
Blue Waters and XSEDE (TG-MCA06N060)
- Emad Tajkhorshid
National Institutes of Health (R01GM121994)
- Da-Neng Wang
National Institutes of Health (R01DK099023)
- Da-Neng Wang
National Institutes of Health (U54GM095315)
- Da-Neng Wang
National Institutes of Health (P41GM104601)
- Emad Tajkhorshid
National Institutes of Health (R01GM067887)
- Emad Tajkhorshid
TESS Research Foundation
- Da-Neng Wang
American Epilepsy Society (AES2017SD3)
- Da-Neng Wang
American Cancer Society (129844-PF-17-135-01-TBE)
- David B Sauer
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Copyright
© 2020, Sauer et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 4,427
- views
-
- 549
- downloads
-
- 47
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Structural Biology and Molecular Biophysics
Polycystin-1 (PC1) is the protein product of the PKD1 gene whose mutation causes autosomal dominant Polycystic Kidney Disease (ADPKD). PC1 is an atypical G protein-coupled receptor (GPCR) with an autocatalytic GAIN domain that cleaves PC1 into extracellular N-terminal and membrane-embedded C-terminal (CTF) fragments. Recently, activation of PC1 CTF signaling was shown to be regulated by a stalk tethered agonist (TA), resembling the mechanism observed for adhesion GPCRs. Here, synthetic peptides of the first 9- (p9), 17- (p17), and 21-residues (p21) of the PC1 stalk TA were shown to re-activate signaling by a stalkless CTF mutant in human cell culture assays. Novel Peptide Gaussian accelerated molecular dynamics (Pep-GaMD) simulations elucidated binding conformations of p9, p17, and p21 and revealed multiple specific binding regions to the stalkless CTF. Peptide agonists binding to the TOP domain of PC1 induced close TOP-putative pore loop interactions, a characteristic feature of stalk TA-mediated PC1 CTF activation. Additional sequence coevolution analyses showed the peptide binding regions were consistent with covarying residue pairs identified between the TOP domain and the stalk TA. These insights into the structural dynamic mechanism of PC1 activation by TA peptide agonists provide an in-depth understanding that will facilitate the development of therapeutics targeting PC1 for ADPKD treatment.
-
- Structural Biology and Molecular Biophysics
BTB (bric-a-brack, Tramtrack, and broad complex) is a diverse group of protein-protein interaction domains found within metazoan proteins. Transcription factors contain a dimerizing BTB subtype with a characteristic N-terminal extension. The Tramtrack group (TTK) is a distinct type of BTB domain, which can multimerize. Single-particle cryo-EM microscopy revealed that the TTK-type BTB domains assemble into a hexameric structure consisting of three canonical BTB dimers connected through a previously uncharacterized interface. We demonstrated that the TTK-type BTB domains are found only in Arthropods and have undergone lineage-specific expansion in modern insects. The Drosophila genome encodes 24 transcription factors with TTK-type BTB domains, whereas only four have non-TTK-type BTB domains. Yeast two-hybrid analysis revealed that the TTK-type BTB domains have an unusually broad potential for heteromeric associations presumably through a dimer-dimer interaction interface. Thus, the TTK-type BTB domains are a structurally and functionally distinct group of protein domains specific to Arthropodan transcription factors.